Merck & Company Inc (MRK) Stock Analysis
$MRK · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
Merck & Company (MRK), a DRUG MANUFACTURERS - GENERAL company, has a market capitalization of about $361.59B and trades at 34.8x trailing earnings.
Price
$146.56
Market cap
$361.59B
P/E ratio
34.8x
Dividend yield
2.62%
About Merck & Company Inc
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.
How StockWorthy values MRK
StockWorthy forecasts Merck & Company Inc's revenue, operating profitability, reinvestment (capital expenditure, depreciation and working capital) and unlevered free cash flow, then discounts those cash flows using a normalized cost of capital built from MRK's size, profitability and balance-sheet risk. Terminal growth is adjusted to reflect the company's mature growth profile rather than a fixed number. The model presents bear, base and bull scenarios, and every key assumption stays transparent and adjustable in the full StockWorthy analysis. Results are educational and not investment advice.
See MRK's Fair Value
Create a free account to view Merck & Company Inc's base-case fair value, the bear–bull modeled range, and every assumption behind them. Free accounts include 5 stock valuations per month — plus Advanced DCF models, financial charts, dividends, and peer analysis.